Guardian Pharmacy Services (GRDN) Cash from Investing Activities (2023 - 2026)

Guardian Pharmacy Services has disclosed Cash from Investing Activities across 4 years of filings, most recently posting -$4.3 million for Q2 2026.

• In Q2 2026, Cash from Investing Activities rose 66.89% year-over-year to -$4.3 million; the TTM figure through Jun 2026 stood at -$22.7 million (up 29.52% YoY), while the FY2025 annual figure was -$32.2 million, down 5.98% from the prior year.
• Cash from Investing Activities came in at -$4.3 million for Q2 2026 at Guardian Pharmacy Services, up from -$4.8 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of -$1.1 million in Q4 2023 to a low of -$13.1 million in Q2 2024.
• Average Cash from Investing Activities over 4 years is -$6.6 million, with a median of -$5.5 million recorded in 2025.
• Year-over-year, Cash from Investing Activities slumped 477.51% in 2024 and jumped 66.89% in 2026.
• Over 4 years, Cash from Investing Activities stood at -$1.1 million in 2023, then tumbled by 477.51% to -$6.6 million in 2024, then climbed by 28.89% to -$4.7 million in 2025, then increased by 8.58% to -$4.3 million in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were -$4.3 million in Q2 2026, -$4.8 million in Q1 2026, and -$4.7 million in Q4 2025.